Auro Laboratories Limited
BSE: AUROLAB.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Sharat Sahadeolal Deorah
- Employees
- 72
- Headquarters
- Mumbai, India
- IPO year
- 2000
- Market cap
- ₹1.7B
- Website
- https://www.aurolabs.com
Loading AUROLAB…
Loading profile data…Frequently asked questions about AUROLAB
What does Auro Laboratories Limited (AUROLAB.BO) do?
Auro Laboratories Ltd. engages in the business of dealing active pharmaceutical ingredients. The firm also offers bulk drugs. The company was founded on May 26, 1989 and is headquartered in Mumbai, India.
Where does AUROLAB.BO trade?
Auro Laboratories Limited (AUROLAB.BO) trades on the Bombay Stock Exchange.
What sector is AUROLAB.BO in?
Auro Laboratories Limited (AUROLAB.BO) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Auro Laboratories Limited?
Sharat Sahadeolal Deorah is the chief executive officer of Auro Laboratories Limited (AUROLAB.BO).
Where is Auro Laboratories Limited headquartered?
Auro Laboratories Limited is headquartered in India.
Does AUROLAB.BO pay a dividend?
Auro Laboratories Limited (AUROLAB.BO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AUROLAB.BO go public?
Auro Laboratories Limited (AUROLAB.BO) completed its initial public offering in 2000.